BioSpace News Archive

The additional proceeds will be used to advance the company’s novel class of oral immunomodulators targeting cytidine triphosphate synthase 1 (CTPS1) to clinical studies.

Vickie is a leader in the financial industry and we are excited to welcome her to OmniGuide’s board of director.

Treatment with HOCl reduced the secretion of inflammatory cytokines in affected skin tissue from NC/Nga mice, including IL-4, IL-13, and TARC.

Mr. Doyle is a thought leader in the field of blockchain and he is dedicated to being a leader in connecting and educating government, organizations, businesses and individuals about blockchain.

The company to host a Capital Markets Day where its R&D and commercial strategy as well as current market dynamics will be updated.

Under the terms of the agreement, Arvinas will access Macroceutics’ DNA-Encoded chemical Libraries to identify binders to multiple targets, which have been historically undruggable through protein inhibition.

The results from 112 boys enrolled in RECENSUS form one of the largest peer-reviewed publications of data illustrating the substantial clinical, humanistic and economic burden of XLMTM.

This new position has been created to support EarlySense’s continued global growth in the hospital, post-acute and consumer health markets and follows the recent success of the new InSight platform and the launch of two new consumer products, Live for the aging population and Percept for couples who are trying to conceive.

A study published in Prostate Cancer and Prostatic Diseases demonstrated that physicians elected to perform fewer biopsies when phi testing was included in their overall, routine, clinical assessment.

The Series A common warrants will be exercisable immediately at an exercise price of$$0.20 per share and will expire five years from the date of issuance.